NA
IDXX icon

NewEdge Advisors’s Idexx Laboratories IDXX Stock Holding History

NewEdge Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.55M Buy
15,221
+5,761
+61% +$3.69M 0.03% 495
2025
Q4 		$6.4M Buy
9,460
+6,780
+253% +$4.62M 0.02% 570
2025
Q3 		$1.71M Buy
2,680
+28
+1% +$17K 0.01% 1097
2025
Q2 		$1.42M Sell
2,652
-153
-5% -$73.2K 0.01% 1096
2025
Q1 		$1.18M Sell
2,805
-8,673
-76% -$3.77M 0.01% 1101
2024
Q4 		$4.75M Buy
11,478
+530
+5% +$232K 0.03% 516
2024
Q3 		$5.53M Buy
10,948
+1,548
+16% +$752K 0.04% 433
2024
Q2 		$4.58M Buy
9,400
+2,506
+36% +$1.26M 0.03% 476
2024
Q1 		$3.72M Buy
6,894
+670
+11% +$366K 0.03% 483
2023
Q4 		$3.43M Buy
6,224
+1,120
+22% +$526K 0.03% 462
2023
Q3 		$2.23M Buy
5,104
+1,114
+28% +$556K 0.02% 565
2023
Q2 		$2M Buy
3,990
+167
+4% +$80K 0.02% 589
2023
Q1 		$1.91M Buy
3,823
+2,116
+124% +$1.01M 0.02% 555
2022
Q4 		$346K Sell
1,707
-4,740
-74% -$1.84M 0.01% 938
2022
Q3 		$2.1M Buy
6,447
+647
+11% +$238K 0.03% 413
2022
Q2 		$2.03M Buy
+5,800
New +$2.37M 0.03% 432
2022
Q1 		– Sell
-5,123
Closed -$3.37M – 1366
2021
Q4 		$3.37M Buy
5,123
+185
+4% +$116K 0.05% 316
2021
Q3 		$3.07M Buy
4,938
+1,715
+53% +$1.15M 0.08% 239
2021
Q2 		$2.04M Buy
3,223
+400
+14% +$221K 0.05% 311
2021
Q1 		$1.38M Buy
2,823
+351
+14% +$176K 0.04% 369
2020
Q4 		$1.24M Buy
2,472
+658
+36% +$294K 0.04% 367
2020
Q3 		$713K Buy
1,814
+537
+42% +$199K 0.02% 470
2020
Q2 		$422K Buy
+1,277
New +$370K 0.02% 585
2017
Q3 		– Sell
-55
Closed -$8.88K – 709
2017
Q2 		$8.88K Buy
+55
New +$8.93K ﹤0.01% 1008

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NewEdge Advisors's IDXX Position: Q1 2026 in Review

NewEdge Advisors increased its Idexx Laboratories (IDXX) stake by 61% in Q1 2026, buying an estimated $3.69M and bringing the position to 15,221 shares worth $8.55M. The position accounts for 0.03% of the portfolio, ranked #495.

NewEdge Advisors first reported a position in IDXX in Q2 2017 and has held it in 24 quarters since. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • NewEdge Advisors held 15,221 shares of Idexx Laboratories worth $8.55M as of Q1 2026.
  • NewEdge Advisors bought 5,761 Idexx Laboratories shares in Q1 2026, an estimated $3.69M.
  • Idexx Laboratories made up 0.03% of NewEdge Advisors's portfolio in Q1 2026, its #495 holding.
  • NewEdge Advisors first reported a position in Idexx Laboratories in Q2 2017 and has held it in 24 quarters since.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.